79 related articles for article (PubMed ID: 7753125)
1. Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease.
Smith RG; Kimura F; Harati Y; McKinley K; Stefani E; Appel SH
Muscle Nerve; 1995 Jun; 18(6):620-7. PubMed ID: 7753125
[TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis.
Smith RG; Hamilton S; Hofmann F; Schneider T; Nastainczyk W; Birnbaumer L; Stefani E; Appel SH
N Engl J Med; 1992 Dec; 327(24):1721-8. PubMed ID: 1331790
[TBL] [Abstract][Full Text] [Related]
4. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
Suh-Kim H; Wei X; Birnbaumer L
Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons.
Engelhardt JI; Siklós L; Kömüves L; Smith RG; Appel SH
Synapse; 1995 Jul; 20(3):185-99. PubMed ID: 7570350
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line.
Mosier DR; Baldelli P; Delbono O; Smith RG; Alexianu ME; Appel SH; Stefani E
Ann Neurol; 1995 Jan; 37(1):102-9. PubMed ID: 7818241
[TBL] [Abstract][Full Text] [Related]
7. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis.
Appel SH; Smith RG; Alexianu M; Siklos L; Engelhardt J; Colom LV; Stefani E
Clin Neurosci; 1995-1996; 3(6):368-74. PubMed ID: 9021258
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line.
Smith RG; Alexianu ME; Crawford G; Nyormoi O; Stefani E; Appel SH
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3393-7. PubMed ID: 8159758
[TBL] [Abstract][Full Text] [Related]
9. The role of immune processes in amyotrophic lateral sclerosis pathogenesis.
Alexianu ME
Rom J Neurol Psychiatry; 1995; 33(3-4):215-27. PubMed ID: 8729177
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line.
Colom LV; Alexianu ME; Mosier DR; Smith RG; Appel SH
Exp Neurol; 1997 Aug; 146(2):354-60. PubMed ID: 9270044
[TBL] [Abstract][Full Text] [Related]
11. The action of amyotrophic lateral sclerosis immunoglobulins on mammalian single skeletal muscle Ca2+ channels.
Magnelli V; Sawada T; Delbono O; Smith RG; Appel SH; Stefani E
J Physiol; 1993 Feb; 461():103-18. PubMed ID: 8394422
[TBL] [Abstract][Full Text] [Related]
12. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
13. Fab fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle.
Delbono O; Magnelli V; Sawada T; Smith RG; Appel SH; Stefani E
Am J Physiol; 1993 Mar; 264(3 Pt 1):C537-43. PubMed ID: 8384783
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
Hu H; Marban E
Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.
Siklós L; Engelhardt J; Harati Y; Smith RG; Joó F; Appel SH
Ann Neurol; 1996 Feb; 39(2):203-16. PubMed ID: 8967752
[TBL] [Abstract][Full Text] [Related]
16. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis.
Alexianu ME; Ho BK; Mohamed AH; La Bella V; Smith RG; Appel SH
Ann Neurol; 1994 Dec; 36(6):846-58. PubMed ID: 7998770
[TBL] [Abstract][Full Text] [Related]
17. Calcium channels in neurological disease.
Greenberg DA
Ann Neurol; 1997 Sep; 42(3):275-82. PubMed ID: 9307247
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to calcium channels in type 1 diabetes mediate autonomic dysfunction by different mechanisms in colon and bladder and are neutralized by antiidiotypic antibodies.
Wan EC; Gordon TP; Jackson MW
J Autoimmun; 2008 Aug; 31(1):66-72. PubMed ID: 18472396
[TBL] [Abstract][Full Text] [Related]
20. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
